References
- Chen S, Qin M, Han Y, et al. (2016). Assessment of the efficacy of drug transdermal delivery by electro-phonophoresis in treating tuberculous lymphadenitis. Drug Deliv 23:1588–93
- Kost J, Pliquett U, Mitragotri S, et al. (1996). Synergistic effect of electric field and ultrasound on transdermal transport. Pharm Res 13:633–8
- Maggi N, Pasqualucci CR, Ballotta R, Sensi P. (1966). Rifampicin: a new orally active rifamycin. Chemotherapy 11:285–92
- Paudel KS, Milewski M, Swadley CL, et al. (2010). Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 1:109–31
- Polat BE, Hart D, Langer R, Blankschtein D. (2011). Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J Control Release 152:330–48
- Prausnitz MR, Bose VG, Langer R, Weaver JC. (1993). Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 90:10504–8
- Prausnitz MR, Langer R. (2008). Transdermal drug delivery. Nat Biotechnol 26:1261–8
- Prausnitz MR, Mitragotri S, Langer R. (2004). Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3:115–24
- Ueda H, Sugibayashi K, Morimoto Y. (1995). Skin penetration-enhancing effect of drugs by phonophoresis. J Control Release 37:291–7
- Wiedersberg S, Guy RH. (2014). Transdermal drug delivery: 30+ years of war and still fighting. J Control Release 190:150–6
- Zorec B, Becker S, Rebersek M, et al. (2013). Skin electroporation for transdermal drug delivery: the influence of the order of different square wave electric pulses. Int J Pharm 457:214–23